Finite Methods as a Ground for Obviousness
Contributed by Knobbe Martens. Originally published on Patexia; republished here as part of the LexDana archive.
Written by: Brok S. Humbert & Adam Powell
UBER TECHNOLOGIES, INC. v. X ONE, INC.
Before Prost, Dyk, and Wallach. Appeal from the U.S. Patent and Trademark Office, Patent Trial and Appeal Board.
Summary: Because a mapping technique must be performed on either a server or a terminal, using a server-side technique disclosed in one piece of prior art was a “predictable variation” of the terminal-side technique disclosed in another piece of prior art.
Uber petitioned for IPR of X One’s patent. The claims generally related to a remote server creating a map, populating it with group-members’ locations, and then transmitting the map to a user’s device. The PTAB considered two pieces of prior art: Okubo and Konishi. Okubo disclosed creating a terminal-side method wherein the map is created on a user’s device and then populated with group members’ locations. Konishi disclosed a server-side method of mapping vehicles. The Board held the patent was not obvious because Konishi’s server-side plotting would be a “wholesale modification to Okubo.” Uber appealed.
The Federal Circuit reversed, stating that Okubo and Konishi demonstrate there are two finite and predictable methods of map-plotting in the field of location-sharing: server-side and terminal-side. Because a person of ordinary skill in the art would have to choose between one of those two methods, using the server-side method disclosed in Konishi was a “predictable variation” of Okubo.
Editor: Paul Stewart
More insights
Federal Circuit Affirms Invalidation of Patent for Lack of Enablement of Claims Directed to a Method of Treating a Patient with a Unit Dosage in Wyeth Llc v Astrazeneca Pharmaceuticals Lp
Written by : Eric Furman, Ph.D. and Ashley C. Morales Key Takeaway: Federal Circuit invalidates patent claims directed to a method for treating non-small cell lung cancer through administration of “a unit dosage” of an irreversible epidermal…
When About Becomes Indefinite Federal Circuit Provides Guidance for Life Science Patent Applications Regarding Limits of Approximation in Enviro Tech v Safe Foods
Written by : Jason J. Jardine and Kenneth O. Aruda, Ph.D. Key Takeaway: The term “about” remains useful in biotech and pharmaceutical claims, but only if the patent provides objective guidance about what the term means. Absent that guidance,…
When Any Patent Means No Patent Federal Circuit Reverses Non Specific Verdict
Written by : Brian C. Barnes and Sophia F. Zahn OLLNOVA TECHNOLOGIES LTD. v. ECOBEE TECHNOLOGIES ULC [OPINION] Before Chen , Cunningham, and Stark. Appeal from the United States District Court for the Eastern District of Texas. Summary : A verdict form…